Acadian Asset Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
Acadian Asset Management's NEO Position: Q2 2026 in Review
Acadian Asset Management sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 797 shares — an estimated $5K sold.
Acadian Asset Management first reported a position in NEO in Q1 2014 and held it in 6 quarters. The position peaked at $184K in Q3 2015. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Acadian Asset Management reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
- Acadian Asset Management sold 797 NeoGenomics shares in Q2 2026, an estimated $5K.
- Acadian Asset Management first reported a position in NeoGenomics in Q1 2014 and held it in 6 quarters.
- Acadian Asset Management's NeoGenomics position peaked at $184K in Q3 2015.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.